Scientific publications

  • EASL Congress Survodutide - Obesity

    Glucagon and GLP-1 receptor dual agonist survodutide improved liver histology in people with MASH and fibrosis: Results from a randomized, double-blind, placebo-controlled phase 2 trial

  • Diabetes, Obesity and Metabolism Survodutide - Obesity

    The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection

  • The Lancet Survodutide - Obesity

    Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

  • Diabetalogia Survodutide - Obesity

    Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

  • Obesity Week Petrelintide - Obesity

    Safety, Tolerability, and Clinical Effects of ZP8396, an Amylin Analog: Multiple Ascending Dose Trial

  • Obesity Week Petrelintide - Obesity

    Potent Weight Loss Effects of Amylin Analog ZP8396 in Combination with Tirzepatide in DIO Rats

  • Diabetes Care Dasiglucagon - Type 1 diabetes

    Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial

  • ADA Scientific Sessions Petrelintide - Obesity

    Safety, Tolerability, and Clinical Effects of ZP8396, a Novel Long Acting Amylin Analog: A Single Ascending Dose Rrial

  • Diabetalogia Dasiglucagon - Type 1 diabetes

    Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial

  • Diabetes, Obesity and Metabolism Survodutide - Obesity

    Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906